These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25030374)

  • 1. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
    Malik R; Patel L; Prensner JR; Shi Y; Iyer MK; Subramaniyan S; Carley A; Niknafs YS; Sahu A; Han S; Ma T; Liu M; Asangani IA; Jing X; Cao X; Dhanasekaran SM; Robinson DR; Feng FY; Chinnaiyan AM
    Mol Cancer Res; 2014 Aug; 12(8):1081-7. PubMed ID: 25030374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.
    Sakurai K; Reon BJ; Anaya J; Dutta A
    Mol Cancer Res; 2015 May; 13(5):828-38. PubMed ID: 25700553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155 downregulates long noncoding RNA prostate cancer-associated transcript 29 in hepatocellular carcinoma to suppress cancer cell invasion and migration.
    Yang M; Yu P; Li P; Diao G
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23493. PubMed ID: 37661808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCARA5 as a downstream factor of PCAT29, inhibits proliferation, migration, and invasion of bladder cancer.
    Lu XS; Huang ML; Chen LB; Liu SC; Huang ZX; Liu SM
    Genomics; 2023 Sep; 115(5):110667. PubMed ID: 37315873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21 Targets Long Noncoding RNA PCAT29 to Promote Cell Proliferation in Neuroblastoma.
    Jiang Z; Zhou X; Han L; Li F; Hao X; Dong Q; Chen X
    Crit Rev Eukaryot Gene Expr; 2022; 32(8):1-8. PubMed ID: 36017911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol.
    Al Aameri RFH; Sheth S; Alanisi EMA; Borse V; Mukherjea D; Rybak LP; Ramkumar V
    PLoS One; 2017; 12(5):e0177198. PubMed ID: 28467474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma.
    Gou Q; Gao L; Nie X; Pu W; Zhu J; Wang Y; Liu X; Tan S; Zhou JK; Gong Y; He J; Wu K; Xie Y; Zhao W; Dai L; Liu L; Xiang R; Wei YQ; Zhang L; Peng Y
    Cancer Res; 2018 Aug; 78(15):4163-4174. PubMed ID: 29735546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PCAT29 regulates the growth, migration and invasion of human triple-negative breast cancer cells.
    Lu C; Li HL; Zhang X; Zhao J; Zheng WH
    J BUON; 2020; 25(2):621-626. PubMed ID: 32521844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling.
    Li Z; Teng J; Jia Z; Zhang G; Ai X
    J Clin Lab Anal; 2021 Feb; 35(2):e23645. PubMed ID: 33219721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
    Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
    J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
    Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
    Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression.
    Wu G; Dong Z; Dong Y; Chen Y; Zhu H; Ding D; Cui Y; Wang Y; Xu Y; Chen H
    Cancer Sci; 2024 May; 115(5):1492-1504. PubMed ID: 38476086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation.
    Saha S; Kiran M; Kuscu C; Chatrath A; Wotton D; Mayo MW; Dutta A
    Cancer Res; 2020 Mar; 80(5):950-963. PubMed ID: 31900260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
    Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
    Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
    Fan L; Li H; Wang W
    Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.